Dysregulation of SOCS-Mediated negative Feedback of Cytokine Signaling in Carcinogenesis and its Significance in Cancer Treatment

被引:84
作者
Jiang, Mengmeng [1 ,2 ]
Zhang, Wen-wen [1 ,2 ]
Liu, Pengpeng [3 ]
Yu, Wenwen [1 ,2 ]
Liu, Ting [1 ,2 ]
Yu, Jinpu [1 ,2 ,3 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Immunol,Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Canc Mol Diagnost Ctr,Key Lab Canc Prevent & Ther, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
SOCS1; SOCS3; dysregulation; carcinogenesis; immune cells; target therapy; DENDRITIC CELLS; BREAST-CANCER; UP-REGULATION; TUMOR-DEVELOPMENT; PROSTATE-CANCER; GENE-EXPRESSION; ANTIGEN PRESENTATION; ANTITUMOR IMMUNITY; MYELOID-LEUKEMIA; HODGKIN LYMPHOMA;
D O I
10.3389/fimmu.2017.00070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Suppressor of cytokine signaling (SOCS) proteins are major negative feedback regulators of cytokine signaling mediated by the Janus kinase (JAK)-signal transducer and activator of transcription signaling pathway. In particular, SOCS1 and SOCS3 are strong inhibitors of JAKs and can play pivotal roles in the development and progression of cancers. The abnormal expression of SOCS1 and SOCS3 in cancer cells is associated with the dysregulation of cell growth, migration, and death induced by multiple cytokines and hormones in human carcinomas. In addition, the mechanisms involved in SOCS1- and SOCS3-regulated abnormal development and activation of immune cells in carcinogenesis, including T cells, macrophages, dendritic cells, and myeloidderived suppressor cells, are still unclear. Therefore, this study aims to further discuss the molecules and signal pathways regulating the expression and function of SOCS1 and SOCS3 in various types of cancers and elucidate the feasibility and efficiency of SOCS-based target therapeutic strategy in anticancer treatment.
引用
收藏
页数:11
相关论文
共 102 条
[1]   The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[2]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[3]   miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells [J].
Amodio, Nicola ;
Bellizzi, Dina ;
Leotta, Marzia ;
Raimondi, Lavinia ;
Biamonte, Lavinia ;
D'Aquila, Patrizia ;
Di Martino, Maria Teresa ;
Calimeri, Teresa ;
Rossi, Marco ;
Lionetti, Marta ;
Leone, Emanuela ;
Passarino, Giuseppe ;
Neri, Antonino ;
Giordano, Antonio ;
Tagliaferri, Pierosandro ;
Tassone, Pierfrancesco .
CELL CYCLE, 2013, 12 (23) :3650-3662
[4]   Inhibition of IL-6 family cytokines by SOCS3 [J].
Babon, Jeffrey J. ;
Varghese, Leila N. ;
Nicola, Nicos A. .
SEMINARS IN IMMUNOLOGY, 2014, 26 (01) :13-19
[5]   Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity [J].
Babon, Jeffrey J. ;
Kershaw, Nadia J. ;
Murphy, James M. ;
Varghese, Leila N. ;
Laktyushin, Artem ;
Young, Samuel N. ;
Lucet, Isabelle S. ;
Norton, Raymond S. ;
Nicola, Nicos A. .
IMMUNITY, 2012, 36 (02) :239-250
[6]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[7]   Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis [J].
Chan, S. R. ;
Rickert, C. G. ;
Vermi, W. ;
Sheehan, K. C. F. ;
Arthur, C. ;
Allen, J. A. ;
White, J. M. ;
Archambault, J. ;
Lonardi, S. ;
McDevitt, T. M. ;
Bhattacharya, D. ;
Lorenzi, M. V. ;
Allred, D. C. ;
Schreiber, R. D. .
CELL DEATH AND DIFFERENTIATION, 2014, 21 (02) :234-246
[8]   SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia [J].
Chen, CY ;
Tsay, W ;
Tang, JL ;
Shen, HL ;
Lin, SW ;
Huang, SY ;
Yao, M ;
Chen, YC ;
Shen, MC ;
Wang, CH ;
Tien, HF .
GENES CHROMOSOMES & CANCER, 2003, 37 (03) :300-305
[9]  
Cheng X-Q, 2015, SHI JIE HUA REN XIAO, V23, P1568
[10]   miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling [J].
Collins, Aideen S. ;
McCoy, Claire E. ;
Lloyd, Andrew T. ;
O'Farrelly, Cliona ;
Stevenson, Nigel J. .
PLOS ONE, 2013, 8 (07)